According to Gram Research analysis of 18 studies involving 1,981 newborns, vitamin D deficiency is significantly associated with increased infection risk in critically ill babies: those with low vitamin D were 2.3 times more likely to develop serious blood infections and needed breathing machines 1.7 times more often than babies with adequate vitamin D levels. However, this research shows association, not proof that supplementation helps, and more studies are needed.
A major analysis of 18 studies involving nearly 2,000 newborns in intensive care found that babies with low vitamin D levels were more than twice as likely to develop dangerous blood infections compared to babies with adequate vitamin D. These babies also needed breathing machines more often and stayed in the hospital longer. While vitamin D deficiency didn’t affect survival rates or lung disease in this analysis, the findings suggest that maintaining healthy vitamin D levels might help protect critically ill newborns from infections. Researchers say more studies are needed to test whether giving vitamin D supplements could improve outcomes for these vulnerable patients.
Key Statistics
A 2026 meta-analysis of 18 studies involving 1,981 critically ill newborns found that those with vitamin D deficiency had 2.31 times higher odds of developing serious blood infections compared to babies with adequate vitamin D levels.
According to research reviewed by Gram, newborns with vitamin D deficiency in intensive care required mechanical ventilation 1.67 times more often and stayed in the hospital approximately 4.5 days longer than those with sufficient vitamin D.
A comprehensive 2026 analysis of neonatal vitamin D research found that vitamin D deficiency was associated with increased infection risk in both premature babies (2.05 times higher odds) and full-term babies (3.96 times higher odds) in intensive care.
The 2026 meta-analysis found no significant difference in survival rates or lung disease development between critically ill newborns with vitamin D deficiency and those with adequate levels, suggesting vitamin D’s primary impact is on infection prevention.
The Quick Take
- What they studied: Whether newborns in intensive care with low vitamin D levels have worse health outcomes, including infections, breathing problems, and hospital stay length.
- Who participated: 1,981 newborns (both premature and full-term) admitted to neonatal intensive care units across 18 different studies. Researchers measured their vitamin D levels when they arrived at the hospital.
- Key finding: Newborns with vitamin D deficiency were 2.3 times more likely to develop serious blood infections, needed breathing machines 1.7 times more often, and stayed in the hospital about 4.5 days longer than babies with adequate vitamin D.
- What it means for you: If you have a newborn in intensive care, vitamin D status may be worth monitoring. However, this research shows associations, not proof that vitamin D supplements will help—doctors should discuss individual cases before making treatment decisions.
The Research Details
Researchers searched four major medical databases for all published studies comparing vitamin D levels in newborns admitted to intensive care units. They found 18 studies that met their strict criteria, involving 1,981 babies total. The studies measured vitamin D levels (specifically 25-hydroxyvitamin D) when babies first arrived at the hospital, then tracked what happened to them—whether they developed infections, needed breathing machines, how long they stayed, and whether they survived.
Because different studies used slightly different definitions of ’low’ vitamin D, researchers did additional analysis using a standard cutoff (30 ng/mL or lower = deficient, above 30 = adequate). They combined all the results using statistical methods that account for differences between studies.
This approach is powerful because it pools data from many studies to find patterns that might not be obvious in any single study. However, the researchers noted that the studies were quite different from each other in important ways, which makes the results less certain.
Newborns in intensive care are extremely vulnerable to infections and complications. If vitamin D deficiency is connected to worse outcomes, doctors might be able to help by checking vitamin D levels and correcting them early. This meta-analysis approach is important because individual studies on this topic are small and sometimes show conflicting results—combining them gives a clearer picture.
The analysis included 18 peer-reviewed studies published in reputable medical journals. However, the studies varied significantly in how they measured vitamin D, defined deficiency, and tracked outcomes. This variation (called ‘heterogeneity’) makes the results less reliable than if all studies had used identical methods. The researchers were transparent about this limitation. The studies were observational (watching what happened naturally) rather than randomized trials where some babies would receive vitamin D supplements—so we can’t be certain vitamin D deficiency causes the problems, only that they’re associated.
What the Results Show
Newborns with vitamin D deficiency had significantly higher rates of serious blood infections (sepsis): their odds were 2.31 times higher than babies with adequate vitamin D. This finding held true for both premature babies (2.05 times higher odds) and full-term babies (3.96 times higher odds), suggesting the connection is real across different newborn populations.
Babies with low vitamin D also needed mechanical ventilation (breathing machines) more often—1.67 times more likely than those with adequate vitamin D. Additionally, they stayed in the hospital about 4.5 days longer on average.
Surprisingly, vitamin D deficiency was not associated with differences in death rates or the development of bronchopulmonary dysplasia (a chronic lung condition common in premature babies). This suggests vitamin D’s main impact in critically ill newborns may be on infection risk rather than survival or long-term lung disease.
When researchers looked specifically at babies with very low vitamin D (30 ng/mL or below), they found no significant difference in hospital stay length compared to those with slightly higher levels. This suggests there may not be a simple dose-response relationship—in other words, getting vitamin D from 20 to 30 ng/mL might not help as much as getting it above 30 ng/mL. The analysis also revealed that the connection between vitamin D and sepsis was consistent across both premature and full-term babies, indicating this is a broad pattern rather than specific to one group.
This is the first comprehensive meta-analysis specifically examining vitamin D deficiency in critically ill newborns. Previous research has shown that vitamin D plays important roles in immune function and fighting infections in adults and older children. This analysis confirms that pattern extends to newborns in intensive care. However, the finding that vitamin D didn’t affect mortality or lung disease differs from some adult studies, suggesting newborns may respond differently to vitamin D deficiency than older patients.
The biggest limitation is that these studies were observational—researchers watched what happened naturally rather than randomly assigning some babies to receive vitamin D supplements. This means we can’t prove that low vitamin D causes infections; it’s possible that sicker babies simply have lower vitamin D levels as a result of their illness. The studies used different definitions of vitamin D deficiency and measured outcomes differently, making it harder to combine results accurately. Most studies were small, and some important information (like exact vitamin D dosing in some cases) was missing. Finally, the research doesn’t tell us whether giving vitamin D supplements would actually prevent infections or improve outcomes.
The Bottom Line
Current evidence suggests monitoring vitamin D levels in newborns admitted to intensive care is reasonable, as deficiency is associated with increased infection risk. However, there is insufficient evidence to recommend routine vitamin D supplementation in critically ill newborns outside of research studies. Any supplementation decisions should be made by the neonatal care team based on individual circumstances. Confidence level: Moderate for the association; Low for treatment recommendations.
Parents of newborns in intensive care should be aware of this research and discuss vitamin D status with their medical team. Neonatal intensive care doctors and researchers should consider this evidence when designing future studies. This research is less relevant for healthy newborns or those not in critical care. Healthcare systems should consider whether routine vitamin D screening in NICU admissions is warranted.
If vitamin D supplementation were to be used, benefits would likely appear over weeks to months as immune function improves, not immediately. Infection rates would be the first measurable outcome. Long-term benefits (if any) would require follow-up studies tracking babies after discharge.
Frequently Asked Questions
Does low vitamin D cause infections in newborns?
Research shows newborns with low vitamin D in intensive care have significantly higher infection rates, but this doesn’t prove vitamin D deficiency causes infections. Sicker babies may develop low vitamin D as a result of illness. More studies are needed to determine if supplementation prevents infections.
Should all newborns in the NICU get vitamin D supplements?
Current evidence doesn’t support routine supplementation for all NICU babies. While low vitamin D is associated with worse outcomes, no studies have proven that supplements improve outcomes. Individual decisions should be made by the neonatal care team based on each baby’s specific situation.
What vitamin D level is considered deficient in newborns?
This analysis used 30 ng/mL as the cutoff—below 30 is considered deficient, above 30 is adequate. However, different studies use different definitions, and the optimal vitamin D level specifically for critically ill newborns hasn’t been established.
Can vitamin D deficiency affect a newborn’s survival?
This analysis of 18 studies found no significant difference in death rates between newborns with low versus adequate vitamin D. However, low vitamin D was linked to more infections and longer hospital stays, which indirectly affect overall health.
How long does it take to see benefits from vitamin D supplementation?
This research doesn’t address supplementation timing because no randomized trials were included. If vitamin D were to help, benefits would likely appear over weeks to months as immune function improves, not immediately.
Want to Apply This Research?
- For parents of NICU babies: Track your baby’s vitamin D level at admission and any follow-up measurements, along with dates of any infections or complications. Note when vitamin D levels are checked and what the results are.
- If your baby is in the NICU, ask your medical team about vitamin D screening and status. Request that vitamin D levels be checked as part of routine admission labs. Discuss any results with your care team and ask whether supplementation is appropriate for your baby’s situation.
- Keep a record of your baby’s vitamin D measurements throughout the NICU stay. Note any infections, breathing support needs, and hospital stay duration. Share this information with your pediatrician at follow-up visits to establish baseline health patterns.
This research shows associations between vitamin D deficiency and worse outcomes in critically ill newborns, but does not prove that vitamin D deficiency causes these problems or that supplementation will help. This analysis is for informational purposes only and should not replace professional medical advice. Parents of newborns in intensive care should discuss vitamin D status and any potential supplementation with their neonatal care team. Do not give any supplements to a newborn without explicit medical guidance. The findings are limited by study heterogeneity and the observational nature of included studies.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.